![]() |
Volumn 9, Issue 5, 2002, Pages 1027-1031
|
The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
DRUG DERIVATIVE;
FLUOROURACIL;
KI 67 ANTIGEN;
PACLITAXEL;
TAXOID;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
APOPTOSIS;
ARTICLE;
BIOSYNTHESIS;
BREAST TUMOR;
CELL DIVISION;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
MIDDLE AGED;
NICK END LABELING;
PAGET NIPPLE DISEASE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
BREAST NEOPLASMS;
CARCINOMA, INTRADUCTAL, NONINFILTRATING;
CELL DIVISION;
CHEMOTHERAPY, ADJUVANT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
FLUOROURACIL;
HUMANS;
IMMUNOHISTOCHEMISTRY;
IN SITU NICK-END LABELING;
KI-67 ANTIGEN;
MIDDLE AGED;
PACLITAXEL;
TAXOIDS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0036730946
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.9.5.1027 Document Type: Article |
Times cited : (22)
|
References (0)
|